Conference abstract · 7 Dec 2018
Conference abstractPublished 2 Nov 2015
Compensatory angiogenesis and tumor refractoriness
Swami Ramanand Teerth Marathwada University, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Since the establishment of tumor angiogenesis as a therapeutic target, an excitement in developing the anti-angiogenic agents was resulted in tailoring a humanized monoclonal antibody (Bevacizumab) against vascular endothelial growth factor (VEGF): A key factor in recruiting angiogenesis. The past three decades’ research in the area of angiogenesis also invented a series of novel and effective anti-angiogenic agents targeting the VEGF signaling axis. Despite the demonstrable clinical benefits of anti-angiogenic therapy, the preclinical and clinical data of the current therapeutic settings clearly indicate the transient efficacy, restoration of tumor progression and aggressive recurrence of tumor invasion after the withdrawal of anti-angiogenic therapy. Therefore, the impact of this therapeutic regime on improving overall survival of patients has been disappointing in clinic. The recent advances in patho-physiology of tumor angiogenesis and related molecular and cellular under-pinning attributed the conspiracy of compensatory angiogenic pathways in conferring evasive and intrinsic tumor resistance to anti-angiogenic agents. The understandings of how these pathways functionally cross-talk for sustaining tumor angiogenesis during VEGF blockade is essential and perhaps may act as a basic prerequisite for designing novel therapeutic strategies to combat the growing arrogance of tumors toward anti-angiogenic agents. An elaborative discourse on major compensatory angiogenic pathways operating at cellular and molecular levels and their attributes with resistance to anti-angiogenic agents along with strategic opinions on future setting in targeting tumor angiogenesis will be discussed.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 27 Sep 2017
Discovery of apoptotic compensatory proliferation signaling and its implication in tumor biology and cancer therapy
Commentary · 27 Nov 2024
Harnessing Tumor Angiogenesis Pathways for Anti-Cancer Drug Development
Editorial · 29 Aug 2024
Therapeutic Approaches to Targeting Angiogenesis in Solid Tumors
Commentary · 11 Jan 2024
Breast Tumor Angiogenesis: Mechanisms, Therapeutic Approaches, and Future Prospects
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Rajesh N Gacche”
